Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
#StayHome: Hydroxychloroquine for COVID-19 Outpatients
NCT04385264Phase 3Withdrawn
- Sponsor
- University of Lausanne
- Start
- Jan 2022
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydroxychloroquine in coronavirus disease 2019 (COVID-19), sponsored by University of Lausanne. Planned start Jan 2022; status: withdrawn.
02
Drugs
hydroxychloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04385264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04385264.